Pamidronate decreases tumor-induced osteoclastogenesis in osteopetrotic mice (Q43716624)

26 November 2017

title

Pamidronate decreases tumor-induced osteoclastogenesis in osteopetrotic mice (English)

1 reference

26 November 2017

Clohisy DR

1

1 reference

26 November 2017

O' Keefe PF

series ordinal

2

1 reference

26 November 2017

Ramnaraine ML

series ordinal

3

1 reference

26 November 2017

publication date

1 July 2001

1 reference

Journal of Orthopaedic Research

26 November 2017

published in

1 reference

26 November 2017

volume

19

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

554-558

1 reference

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2800%2900065-6

Effect of a newly developed bisphosphonate, YH529, on osteolytic bone metastases in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2800%2900065-6

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2800%2900065-6

Osteoblastic cells are involved in osteoclast formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2800%2900065-6

Cytochemical methods for the detection of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2800%2900065-6

Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2800%2900065-6

Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2800%2900065-6

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2800%2900065-6

Tumor osteolysis in osteopetrotic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2800%2900065-6

Osteoclast formation during tumor osteolysis does not require proliferating osteoclast precursor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2800%2900065-6

Osteoclasts are required for bone tumors to grow and destroy bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2800%2900065-6

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2800%2900065-6

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2800%2900065-6

Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0736-0266%2800%2900065-6

10.1016/S0736-0266(00)00065-6

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference